Curaleaf Holdings (CURLF) Current Deferred Revenue (2022 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Current Deferred Revenue of $3.0 million for Q4 2025, down 91.03% year-on-year from $33.1 million in Q4 2024, and down 91.03% on a QoQ basis from $33.1 million in Q4 2024.

Curaleaf Holdings (CURLF) Current Deferred Revenue (2022 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Current Deferred Revenue for 4 consecutive years, with $3.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Current Deferred Revenue fell 91.03% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (down 91.03% YoY) and the FY2025 annual result came in at $3.0 million, down 91.03% from the prior year.
  • Current Deferred Revenue declined to $3.0 million in Q4 2025 per CURLF's latest filing, from $33.1 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for CURLF reached as high as $33.1 million in Q4 2024 and fell as low as $3.0 million in Q4 2025.
  • A 4-year average of $21.8 million and a median of $23.5 million in 2022 frame the typical range for Current Deferred Revenue.
  • Annual changes were most pronounced in 2024 — Current Deferred Revenue soared 48.01% — and 2025, when it slumped 91.03%.
  • Year by year, Current Deferred Revenue stood at $24.4 million in 2022, then dropped by 8.61% to $22.3 million in 2023, then surged by 48.01% to $33.1 million in 2024, then sank by 91.03% to $3.0 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $3.0 million, $33.1 million, and $22.6 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.97 Mn
Dec 31, 2024 33.07 Mn
Sep 30, 2024 22.64 Mn
Jun 30, 2024 25.41 Mn
Dec 31, 2023 22.34 Mn
Dec 31, 2022 24.45 Mn